Paper39128337
Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations.
Tee XR and 13 others. Gynecol Oncol, 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations. Papers, record 39128337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39128337
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Germ-Line Mutation | Major topic |
| Tumor Suppressor Protein p53 | Major topic |
| Ovarian Neoplasms | Major topic |
| BRCA1 Protein | Major topic |
| Humans | |
| Female | |
| Middle Aged | |
| Adult | |
| Aged | |
| High-Throughput Nucleotide Sequencing | |
| Cystadenocarcinoma, Serous | |
| Genes, BRCA1 |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA015704 | NCI NIH HHS | United States | P30CA015704 | PubMed | NIH RePORTER |
| R01 CA259384 | NCI NIH HHS | United States | R01CA259384 | PubMed and NIH | NIH RePORTER |
| R21 CA240885 | NCI NIH HHS | United States | R21CA240885 | PubMed and NIH | NIH RePORTER |
| T32 CA009515 | NCI NIH HHS | United States | T32CA009515 | PubMed | NIH RePORTER |
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32025013 | The evolutionary history of 2,658 cancers. | Nature | 2020 | https://conductscience.org/library/papers/32025013 | PubMed |
| 2 | 33422951 | Insights into clonal hematopoiesis and its relation to cancer risk. | Curr Opin Genet Dev | 2021 | https://conductscience.org/library/papers/33422951 | PubMed |
| 3 | 16731090 | Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy. | Am J Obstet Gynecol | 2006 | https://conductscience.org/library/papers/16731090 | PubMed |
| 4 | 26493647 | Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. | Nat Rev Cancer | 2015 | https://conductscience.org/library/papers/26493647 | PubMed |
| 5 | 36930945 | Clonal Evolution in Healthy and Premalignant Tissues: Implications for Early Cancer Interception Strategies. | Cancer Prev Res (Phila) | 2023 | https://conductscience.org/library/papers/36930945 | PubMed |
| 6 | 36049115 | Clonal hematopoiesis, somatic mosaicism, and age-associated disease. | Physiol Rev | 2023 | https://conductscience.org/library/papers/36049115 | PubMed |
| 7 | 30503267 | The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma. | Gynecol Oncol | 2019 | https://conductscience.org/library/papers/30503267 | PubMed |
| 8 | 18342932 | A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. | Gynecol Oncol | 2008 | https://conductscience.org/library/papers/18342932 | PubMed |
| 9 | 31839337 | Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma. | Gynecol Oncol | 2020 | https://conductscience.org/library/papers/31839337 | PubMed |
| 10 | 30110635 | Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium. | Cell Rep | 2018 | https://conductscience.org/library/papers/30110635 | PubMed |
| 11 | 32350471 | The mutational landscape of normal human endometrial epithelium. | Nature | 2020 | https://conductscience.org/library/papers/32350471 | PubMed |
| 12 | 38759517 | Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1/2 mutation carriers several years after risk-reducing salpingo-oophorectomy. | Gynecol Oncol | 2024 | https://conductscience.org/library/papers/38759517 | PubMed |
| 13 | 28803919 | Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. | Cell Stem Cell | 2017 | https://conductscience.org/library/papers/28803919 | PubMed |
| 14 | 33627798 | Clonal expansion in non-cancer tissues. | Nat Rev Cancer | 2021 | https://conductscience.org/library/papers/33627798 | PubMed |
| 15 | 36311816 | Uterine lavage identifies cancer mutations and increased TP53 somatic mutation burden in individuals with ovarian cancer. | Cancer Res Commun | 2022 | https://conductscience.org/library/papers/36311816 | PubMed |
| 16 | 24567435 | Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. | J Clin Oncol | 2014 | https://conductscience.org/library/papers/24567435 | PubMed |
| 17 | 38918516 | TP53 somatic evolution in cervical liquid-based cytology and blood from individuals with and without ovarian cancer and BRCA1 or BRCA2 germline mutations. | Oncogene | 2024 | https://conductscience.org/library/papers/38918516 | PubMed |
| 18 | 28632866 | Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. | JAMA | 2017 | https://conductscience.org/library/papers/28632866 | PubMed |
| 19 | 33106634 | Cancer therapy shapes the fitness landscape of clonal hematopoiesis. | Nat Genet | 2020 | https://conductscience.org/library/papers/33106634 | PubMed |
| 20 | 31672865 | Clonal hematopoiesis in human aging and disease. | Science | 2019 | https://conductscience.org/library/papers/31672865 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42686803 | High-grade serous ovarian cancer is associated with increased TP53 mutation burden in uterine lavage. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42686803 | PubMed |
| 41430564 | Microbial metabolite 5-formamidoimidazole-4-carboxamide ribotide targets METTL1 to inhibit m7G modification of BRCA1 mRNA to inhibit high-grade serous ovarian cancer. | Mol Med | 2025 | https://conductscience.org/library/papers/41430564 | PubMed |
| 41062696 | Somatic mutation and selection at population scale. | Nature | 2025 | https://conductscience.org/library/papers/41062696 | PubMed |
| 40325478 | Restoration of TP53 strategy via specific nanoparticles for ovarian cancer therapy. | J Ovarian Res | 2025 | https://conductscience.org/library/papers/40325478 | PubMed |
| 40252048 | Transforming treatment paradigms: Focus on personalized medicine for high-grade serous ovarian cancer. | CA Cancer J Clin | 2025 | https://conductscience.org/library/papers/40252048 | PubMed |
| 40250028 | TP53 somatic evolution in the normal endometrium of Black and White individuals. | Gynecol Oncol | 2025 | https://conductscience.org/library/papers/40250028 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| BioProject | PRJNA1144429 |
Source BioProject
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39128337
GET https://conductscience.org/api/papers/v1/39128337/references?page=2